文献速递其他结缔组织病

屏气试验在系统性硬化症患者中的应用价值

Utility of the breath-holding test in patients with systemic sclerosis.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

研究前瞻性纳入72例系统性硬化症(SSc)患者,评估屏气试验(BHT)与6分钟步行试验(6MWT)、Borg呼吸困难量表、硬皮病健康评估问卷(SHAQ)、肺功能及超声心动图的相关性;另31例患者间隔2周重复BHT评估信度。BHT与Borg量表、SHAQ及肺功能参数显著相关,组内相关系数(2,1)为0.943(95%CI:0.88, 0.97),提示BHT可能是SSc患者肺功能的替代标志物。

要点

  • BHT与Borg呼吸困难量表测试前(r=-0.367,P<0.001)和测试后(r=-0.285,P=0.016)均显著相关。
  • BHT与一氧化碳弥散量(%,r=0.426,P<0.001)、用力肺活量(升,r=0.373,P=0.001)及SHAQ评分(r=-0.470,P<0.001)相关。
  • BHT信度优良,组内相关系数(2,1)为0.943(95%CI:0.88, 0.97)。

核心结论

  • BHT是一种简单且省时的检查,信度优良,与Borg量表、SHAQ及肺功能参数显著相关,结果提示BHT可能作为SSc患者肺功能的替代标志物。

研究设计与样本

  • 前瞻性纳入72例SSc患者,均接受BHT和6分钟步行试验(6MWT),并测量Borg呼吸困难量表和硬皮病健康评估问卷(SHAQ),同时收集肺功能和超声心动图数据。
  • 另纳入31例SSc患者,间隔2周内重复进行BHT以评估信度。
  • 以最佳BHT时间与相关临床参数的相关性评估效度。

主要发现

  • 最佳BHT时间均值(标准差)为38.4(15.7)秒,6MWT距离为473.5(95.5)米。
  • BHT与Borg呼吸困难量表测试前(r=-0.367,P<0.001)和测试后(r=-0.285,P=0.016)均显著相关;6MWT与测试后Borg量表相关(r=-0.351,P=0.002),与测试前不相关(r=-0.113,P=0.343)。
  • BHT时间与一氧化碳弥散量(%,r=0.426,P<0.001)、用力肺活量(升,r=0.373,P=0.001)、肺动脉收缩压(mmHg,r=-0.272,P=0.031)及SHAQ评分(r=-0.470,P<0.001)相关,但与左心室射血分数(%,r=-0.135,P=0.263)不相关。
  • BHT信度优良,组内相关系数(2,1)为0.943(95%CI:0.88, 0.97)。

临床怎么用

  • 作者认为BHT可能作为SSc患者肺功能的替代标志物。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Cardiopulmonary involvement is a major cause of death in patients with SSc. This study evaluated the clinical utility and reliability of breath-holding test (BHT) in evaluating cardiopulmonary function in patients with SSc. METHODS: Seventy-two prospectively enrolled patients with SSc underwent BHT and the 6 min walk test (6MWT), along with measurements of the Borg dyspnoea scale and Scleroderma Health Assessment Questionnaire (SHAQ). Data on pulmonary function test and echocardiography were also collected. Validity was assessed based on the correlations between the best BHT and relevant clinical parameters. To assess the reliability of BHT, an additional 31 patients with SSc underwent BHTs twice within 2 week intervals. RESULTS: Mean (s.d.) best BHT time was 38.4 (15.7) s, and 6MWT distance was 473.5 (95.5) m. BHT showed significant correlations with the Borg dyspnoea scale before (r = -0.367, P < 0.001) and after (r = -0.285, P = 0.016) testing, whereas 6MWT were correlated with the Borg dyspnoea scale after (r = -0.351, P = 0.002) but not before (r = -0.113, P = 0.343) testing. BHT time was correlated with diffusing capacity for carbon monoxide (%, r = 0.426, P < 0.001), forced vital capacity (litres, r = 0.373, P = 0.001), pulmonary arterial systolic pressure (mmHg, r = -0.272, P = 0.031) and SHAQ score (r = -0.470, P < 0.001), but not with left ventricular ejection fraction (%, r = -0.135, P = 0.263). BHT showed excellent reliability, with an intraclass correlation coefficient (2, 1) of 0.943 (95% CI: 0.88, 0.97). CONCLUSION: BHT, a simple and less time-consuming test, shows excellent reliability and significant correlation with the Borg scale, SHAQ and pulmonary parameters. These results suggest that BHT might be a useful surrogate marker of pulmonary capacity in SSc patients. TRIAL REGISTRATION NUMBER: NCT04484948.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Yeo J, Kim JY, Kim MH, et al. Utility of the breath-holding test in patients with systemic sclerosis. Rheumatology (Oxford). 2022. PMID: 35040945. doi:10.1093/rheumatology/keac020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。